TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Ohio Investigators

Eric L. Jenison, MD

McDowell Cancer Center at Akron ...


Akron, Ohio - 44307 (330-344-6448)
  • CLINICAL TRIALS 10
  • CONDITIONS7
  • INTERVENTIONS25
  • SINCE1992
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer

March 2005 - April 2008
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer

April 2009 - December 2011
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

August 2009 - January 2016
Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin

December 2009 - December 2010
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy Paclitaxel and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

March 2009 - March 2013
Paclitaxel Carboplatin and Bevacizumab or Paclitaxel Carboplatin and Temsirolimus or Ixabepilone Carboplatin and Bevacizumab in Treating Patients With Stage III Stage IV or Recurrent Endometrial Cancer

October 2009 - July 2011
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

January 2010 - September 2013
Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer

December 2007 - December 2009
Collecting Tumor Samples From Patients With Gynecological Tumors

June 1992 -
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer Undergoing Chemotherapy

September 2007 -
Ovarian Neoplasms

Fatigue

Peritoneal Neoplasms

Fallopian Tube Neoplasms

Neurotoxicity Syndromes

Endometrial Neoplasms

Uterine Cervical Neoplasms

Intensity-Modulated Radiation Therapy

Laboratory Biomarker Analysis

Questionnaire Administration

Quality-Of-Life Assessment

Educational Intervention

Study Of Socioeconomic And Demographic Variables

Assessment Of Therapy Complications

Psychosocial Assessment And Care

Paclitaxel

Carboplatin

Bevacizumab

Cisplatin

Docetaxel

Radiation Therapy

Belinostat

Temsirolimus

Management Of Therapy Complications

Biologic Sample Preservation Procedure

Ixabepilone

Topotecan Hydrochloride

Clinical Observation

Brachytherapy

Internet-Based Intervention

Paclitaxel Poliglumex

Communication Intervention

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo